ASDAS states in patients stratified by baseline MRI/CRP status.

Por um escritor misterioso
Last updated 16 junho 2024
ASDAS states in patients stratified by baseline MRI/CRP status.
ASDAS states in patients stratified by baseline MRI/CRP status.
Disease stratification in GCA and PMR: state of the art and future perspectives
ASDAS states in patients stratified by baseline MRI/CRP status.
Frontiers White matter integrity as a mediator between socioeconomic status and executive function
ASDAS states in patients stratified by baseline MRI/CRP status.
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
ASDAS states in patients stratified by baseline MRI/CRP status.
Full article: Effectiveness of bDMARDs in ankylosing spondylitis patients by biologic use: experience from the CorEvitas PsA/SpA Registry
ASDAS states in patients stratified by baseline MRI/CRP status.
Evaluation of BASDAI (Panel A) and ASDAS-CRP (Panel B) during
ASDAS states in patients stratified by baseline MRI/CRP status.
IJMS, Free Full-Text
ASDAS states in patients stratified by baseline MRI/CRP status.
Interosseous tendon inflammation in the hands of patients with clinically suspect arthralgia: analysis of MRI data from a prospective cohort study - The Lancet Rheumatology
ASDAS states in patients stratified by baseline MRI/CRP status.
A prognostic risk score for development and spread of chronic pain
ASDAS states in patients stratified by baseline MRI/CRP status.
Frontiers Advanced imaging for risk stratification for ventricular arrhythmias and sudden cardiac death
ASDAS states in patients stratified by baseline MRI/CRP status.
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
ASDAS states in patients stratified by baseline MRI/CRP status.
Myocarditis
ASDAS states in patients stratified by baseline MRI/CRP status.
Improvement in (A) ASAS20 and (B) ASAS40 response rates in patients
ASDAS states in patients stratified by baseline MRI/CRP status.
Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT, Arthritis Research & Therapy

© 2014-2024 miaad.org. All rights reserved.